Search

Harry Y. Oh

Examiner (ID: 6855, Phone: (571)270-5912 , Office: P/3664 )

Most Active Art Unit
3664
Art Unit(s)
4128, 3666, 3657, 3664
Total Applications
785
Issued Applications
654
Pending Applications
54
Abandoned Applications
99

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19512348 [patent_doc_number] => 20240344034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => Renal Progenitor Cells [patent_app_type] => utility [patent_app_number] => 18/757662 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15015 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757662 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/757662
Renal Progenitor Cells Jun 27, 2024 Pending
Array ( [id] => 19709514 [patent_doc_number] => 20250019656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS [patent_app_type] => utility [patent_app_number] => 18/744550 [patent_app_country] => US [patent_app_date] => 2024-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18744550 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/744550
COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS Jun 13, 2024 Pending
Array ( [id] => 19543381 [patent_doc_number] => 20240360417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME [patent_app_type] => utility [patent_app_number] => 18/631774 [patent_app_country] => US [patent_app_date] => 2024-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631774 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/631774
CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME Apr 9, 2024 Pending
Array ( [id] => 18469168 [patent_doc_number] => 20230203452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => METHOD OF PRODUCING CONDITIONED MEDIUM FOR CULTURING PATIENT-DERIVED CANCER CELLS [patent_app_type] => utility [patent_app_number] => 18/171832 [patent_app_country] => US [patent_app_date] => 2023-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18171832 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/171832
METHOD OF PRODUCING CONDITIONED MEDIUM FOR CULTURING PATIENT-DERIVED CANCER CELLS Feb 20, 2023 Pending
Array ( [id] => 19800797 [patent_doc_number] => 20250066722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => METHODS FOR PRODUCTION OF FUNCTIONAL NEURONS [patent_app_type] => utility [patent_app_number] => 18/703641 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18703641 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/703641
METHODS FOR PRODUCTION OF FUNCTIONAL NEURONS Nov 9, 2022 Pending
Array ( [id] => 18583134 [patent_doc_number] => 20230265393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => COMPOSITION AND METHODS FOR PRODUCING ADULT LIVER ORGANOIDS [patent_app_type] => utility [patent_app_number] => 17/935135 [patent_app_country] => US [patent_app_date] => 2022-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935135 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/935135
COMPOSITION AND METHODS FOR PRODUCING ADULT LIVER ORGANOIDS Sep 25, 2022 Pending
Array ( [id] => 18166269 [patent_doc_number] => 20230032871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => Recombinant Viral Particle for Gene and/or Cellular Therapy [patent_app_type] => utility [patent_app_number] => 17/812521 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812521 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812521
Recombinant Viral Particle for Gene and/or Cellular Therapy Jul 13, 2022 Abandoned
Array ( [id] => 17982847 [patent_doc_number] => 20220348883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => HIGH-DENSITY CELL CULTURE METHOD [patent_app_type] => utility [patent_app_number] => 17/863785 [patent_app_country] => US [patent_app_date] => 2022-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863785 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/863785
HIGH-DENSITY CELL CULTURE METHOD Jul 12, 2022 Pending
Array ( [id] => 18140342 [patent_doc_number] => 20230014181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/842715 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842715 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/842715
CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS Jun 15, 2022 Pending
Array ( [id] => 18077728 [patent_doc_number] => 20220403340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 17/839138 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/839138
MEDIA FOR CRYOPRESERVED CELLS AND METHODS OF MAKING AND USING SAME Jun 12, 2022 Pending
Array ( [id] => 18751576 [patent_doc_number] => 20230354789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => INDIRECT SELECTIVE BREEDING METHOD OF HIGH-COLLAGEN MEAT GEESE [patent_app_type] => utility [patent_app_number] => 17/924687 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/924687
INDIRECT SELECTIVE BREEDING METHOD OF HIGH-COLLAGEN MEAT GEESE May 25, 2022 Pending
Array ( [id] => 18160467 [patent_doc_number] => 20230027059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS [patent_app_type] => utility [patent_app_number] => 17/748323 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748323 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748323
METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN NEURAL PROGENITOR CELLS May 18, 2022 Pending
Array ( [id] => 18628487 [patent_doc_number] => 20230287352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD FOR NON-ENZYMATIC 3D CULTURE AND AMPLIFICATION OF MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/739127 [patent_app_country] => US [patent_app_date] => 2022-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739127 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/739127
Method for non-enzymatic 3D culture and amplification of mesenchymal stem cells May 7, 2022 Issued
Array ( [id] => 18285863 [patent_doc_number] => 20230101335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/738843 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33374 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738843 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/738843
EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF May 5, 2022 Pending
Array ( [id] => 17657370 [patent_doc_number] => 20220177835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONS [patent_app_type] => utility [patent_app_number] => 17/681113 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681113
METHODS OF GENERATING AND ISOLATING MIDBRAIN DOPAMINE NEURONS Feb 24, 2022 Pending
Array ( [id] => 17774996 [patent_doc_number] => 20220241345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => INDUCED PLURIPOTENT STEM CELL DERIVED GLIAL ENRICHED PROGENITOR CELLS FOR THE TREATMENT OF WHITE MATTER STROKE [patent_app_type] => utility [patent_app_number] => 17/674708 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674708 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674708
INDUCED PLURIPOTENT STEM CELL DERIVED GLIAL ENRICHED PROGENITOR CELLS FOR THE TREATMENT OF WHITE MATTER STROKE Feb 16, 2022 Pending
Array ( [id] => 18064450 [patent_doc_number] => 20220395537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => METHODS OF STEM CELL CULTURE FOR OBTAINING PRODUCTS, AND IMPLEMENTATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/578442 [patent_app_country] => US [patent_app_date] => 2022-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578442 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/578442
METHODS OF STEM CELL CULTURE FOR OBTAINING PRODUCTS, AND IMPLEMENTATIONS THEREOF Jan 17, 2022 Abandoned
Array ( [id] => 18483606 [patent_doc_number] => 20230210906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => Composite 3D Brain Organoids with Optic Structures, Uses Thereof and Culture Medium for Obtaining Them [patent_app_type] => utility [patent_app_number] => 17/570266 [patent_app_country] => US [patent_app_date] => 2022-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36438 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570266 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/570266
Composite 3D Brain Organoids with Optic Structures, Uses Thereof and Culture Medium for Obtaining Them Jan 5, 2022 Pending
Array ( [id] => 17792411 [patent_doc_number] => 20220251502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => METHODS FOR REDUCING THE OXIDATION LEVEL OF CYSTEINE RESIDUES IN A SECRETED RECOMBINANTLY-EXPRESSED PROTEIN DURING CELL CULTURE [patent_app_type] => utility [patent_app_number] => 17/557921 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557921 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/557921
METHODS FOR REDUCING THE OXIDATION LEVEL OF CYSTEINE RESIDUES IN A SECRETED RECOMBINANTLY-EXPRESSED PROTEIN DURING CELL CULTURE Dec 20, 2021 Pending
Array ( [id] => 18420481 [patent_doc_number] => 20230174943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => CELLULAR COMPOSITION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/543491 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12749 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17543491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/543491
CELLULAR COMPOSITION AND USES THEREOF Dec 5, 2021 Pending
Menu